Medical device recalls

Roche Diagnostics Operations, Inc. recalls Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determina…

Recall date
September 11, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0153-2020
FDA classification
Class III
Brand / firm
Roche Diagnostics Operations, Inc.
Sold / distributed
US Nationwide distribution including the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KY, LA, MA, MD, MI, MO, NE, NH, NJ, NY, OH, OK, PA, PR, RI, SC, TN, TX, UT, VA and WI. Updated as of 12/20/19 to include the following additional US states: CO.

Why it was recalled

Due to low Quality Control recovery and invalid Calibration.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determination of the total bilirubin in serum and plasma of adults and neonates on Roche/Hitachi cobas c systems.

Get recall alerts

Free email alert whenever Roche Diagnostics Operations, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Diagnostics Operations, Inc.